Table 3.
Recovery times in surviving patients according to treatment group
| Quinine (median, IQR) | N | Artesunate (median, IQR) | N | HR (95% CI) | p value | |
|---|---|---|---|---|---|---|
| Time to discharge (days) | 3·0 (2·0–5·0) | 2412 | 3·0 (2·0–5·0) | 2478 | 1·04 (0·99–1·10) | 0·059 |
| Time to eat (h) | 12 (2–24) | 2269 | 9 (0–24) | 2358 | 0·99 (0·93–1·06) | 0·74 |
| Time to sit unsupported (h) | 22 (6–44) | 2312 | 18 (6–42) | 2373 | 1·02 (0·95–1·08) | 0·60 |
| Time to localise pain (h)* | 12 (6–24) | 726 | 12 (6–24) | 698 | 0·87 (0·78–0·98) | 0·0093 |
| Time to speak (h)* | 18 (11–36) | 695 | 20 (8–42) | 664 | 0·88 (0·79–0·99) | 0·016 |
*
Time to localise pain and time to speak was assessed only for surviving patients with coma on admission (Blantyre coma scale <3 or Glasgow coma scale <11).